LAG3 and cancer: Thus, although NK cells might be important players that contribute to the anti-tumor activity of IC inhibitors (ICIs) like antibodies against CTLA-4, LAG3, and the PD1/PD-L1 axes in cancer patients (68), this should not overestimate the function of some T cell-ICs in healthy NK cells.